Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

2.

Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.

Dheekollu J, Malecka K, Wiedmer A, Delecluse HJ, Chiang AK, Altieri DC, Messick TE, Lieberman PM.

Oncotarget. 2017 Jan 31;8(5):7248-7264. doi: 10.18632/oncotarget.14540. Erratum in: Oncotarget. 2019 Jul 08;10(43):4505-4506.

3.

Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.

Sivachandran N, Sarkari F, Frappier L.

PLoS Pathog. 2008 Oct 3;4(10):e1000170. doi: 10.1371/journal.ppat.1000170.

4.

Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.

Zhang Y, Wang H, Liu Y, Wang C, Wang J, Long C, Guo W, Sun X.

Biomed Pharmacother. 2018 Jun;102:1003-1014. doi: 10.1016/j.biopha.2018.03.114. Epub 2018 Apr 5.

PMID:
29710517
5.

Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.

Valentine R, Dawson CW, Hu C, Shah KM, Owen TJ, Date KL, Maia SP, Shao J, Arrand JR, Young LS, O'Neil JD.

Mol Cancer. 2010 Jan 5;9:1. doi: 10.1186/1476-4598-9-1.

6.

EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.

Cai LM, Lyu XM, Luo WR, Cui XF, Ye YF, Yuan CC, Peng QX, Wu DH, Liu TF, Wang E, Marincola FM, Yao KT, Fang WY, Cai HB, Li X.

Oncogene. 2015 Apr 23;34(17):2156-66. doi: 10.1038/onc.2014.341. Epub 2014 Oct 27.

PMID:
25347742
7.

Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer.

Mansouri S, Pan Q, Blencowe BJ, Claycomb JM, Frappier L.

J Virol. 2014 Oct;88(19):11166-77. doi: 10.1128/JVI.01785-14. Epub 2014 Jul 16.

8.

Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.

Sivachandran N, Dawson CW, Young LS, Liu FF, Middeldorp J, Frappier L.

J Virol. 2012 Jan;86(1):60-8. doi: 10.1128/JVI.05623-11. Epub 2011 Oct 19.

9.

Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus.

Westhoff Smith D, Sugden B.

Viruses. 2013 Jan 16;5(1):226-40. doi: 10.3390/v5010226. Review.

10.

Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigenĀ 1-dependent mechanism.

Wang C, Wang H, Zhang Y, Guo W, Long C, Wang J, Liu L, Sun X.

Oncol Rep. 2017 Apr;37(4):2109-2120. doi: 10.3892/or.2017.5489. Epub 2017 Mar 2.

PMID:
28259949
11.

Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.

Zhou H, Liu Y, Wang C, Liu L, Wang H, Zhang Y, Long C, Sun X.

J Exp Clin Cancer Res. 2018 Aug 15;37(1):192. doi: 10.1186/s13046-018-0865-5.

12.

Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells.

Port RJ, Pinheiro-Maia S, Hu C, Arrand JR, Wei W, Young LS, Dawson CW.

J Pathol. 2013 Nov;231(3):367-77. doi: 10.1002/path.4245.

PMID:
23934731
13.

EBNA1.

Frappier L.

Curr Top Microbiol Immunol. 2015;391:3-34. doi: 10.1007/978-3-319-22834-1_1. Review.

PMID:
26428370
14.

Role of EBNA1 in NPC tumourigenesis.

Frappier L.

Semin Cancer Biol. 2012 Apr;22(2):154-61. doi: 10.1016/j.semcancer.2011.12.002. Epub 2011 Dec 22. Review.

PMID:
22206863
15.

Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro.

O'Neil JD, Owen TJ, Wood VH, Date KL, Valentine R, Chukwuma MB, Arrand JR, Dawson CW, Young LS.

J Gen Virol. 2008 Nov;89(Pt 11):2833-42. doi: 10.1099/vir.0.2008/003392-0.

PMID:
18931081
16.

Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.

Stevens SJ, Verkuijlen SA, Hariwiyanto B, Harijadi, Paramita DK, Fachiroh J, Adham M, Tan IB, Haryana SM, Middeldorp JM.

Int J Cancer. 2006 Aug 1;119(3):608-14.

17.

Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.

Chen JN, Zhang NN, Jiang Y, Hui DY, Wen ZJ, Li HG, Ding YG, Du H, Shao CK.

PLoS One. 2012;7(11):e50084. doi: 10.1371/journal.pone.0050084. Epub 2012 Nov 26.

18.

Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections.

Malik-Soni N, Frappier L.

J Virol. 2012 Jun;86(12):6999-7002. doi: 10.1128/JVI.00194-12. Epub 2012 Apr 11. Erratum in: J Virol. 2015 Sep;89(17):9143.

19.

Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells.

Wang L, Tian WD, Xu X, Nie B, Lu J, Liu X, Zhang B, Dong Q, Sunwoo JB, Li G, Li XP.

Cancer. 2014 Feb 1;120(3):363-72. doi: 10.1002/cncr.28418. Epub 2013 Nov 4.

20.

Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.

Chiu SH, Wu CC, Fang CY, Yu SL, Hsu HY, Chow YH, Chen JY.

Oncotarget. 2014 Sep 30;5(18):8583-601.

Supplemental Content

Support Center